The CXCL-12/CXCR4 axis correlates with tumor growth, invasion, angiogenesis and metastasis in CRC, making this chemokine axis to one of the most promising targets for an inhibitory therapy [49]. This evidence concerns the gene CXCL12 and neoplasm.